China Resources Boya Bio-pharmaceutical Group (300294.SZ) announced that the company received notice from the Inner Mongolia Autonomous Region Health...
According to the Zhitong Finance APP, China Resources Boya Bio-pharmaceutical Group (300294.SZ) announced that on January 5, 2025, it received a notice from the Inner Mongolia Autonomous Region Health and Health Committee regarding the approval for setting up the Dalaheqi Boya Plasma Collection Station (Inner Wei Medical Urgent Character [2025] No. 2), allowing the company to establish a plasma collection station in Dalaheqi, Ordos City.
The company will accelerate the construction of this plasma collection station and the processing of related operational registration procedures in accordance with the relevant regulations such as the "Regulations on the Management of Blood Products" and the "Management Measures for Plasma Collection Stations." Subsequently, once the plasma collection station is completed and passes acceptance, it will be conducive to further enhancing the company's supply capacity of raw plasma and improving the company's profitability.
